Hyderabad:
Templeton Strategic Emerging Markets LDC has acquired
13,05,460 equity shares equivalent to 2.9 per cent of
the total paid-up capital of Aurobindo Pharma Ltd (APL).
The
mode of acquisition of the shares was through the open
market and was completed on a single day on April 30,
2004, Templeton Strategic informed the National Stock
Exchange yesterday The shareholding of Templeton Strategic
Emerging Markets after this acquisition stands at 36,79,596
equity shares amounting to 7.9131 per cent of the total
paid-up capital of APL.
The
APL board had allotted one million equity shares and equal
number of share warrants
to Templeton Strategic in April 2002. In addition to Templeton
Strategic, other major foreign institutional investors
(FIIs) in APL are ABN Amro Funds and Copthall Mauritius
Investment Ltd.
|